These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37212330)

  • 1. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ; Chin RFM
    Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-seizure medications for Lennox-Gastaut syndrome.
    Brigo F; Jones K; Eltze C; Matricardi S
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ; Chin RFM
    Expert Rev Neurother; 2024 Mar; 24(3):235-249. PubMed ID: 38315124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
    Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
    Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis.
    Devi N; Madaan P; Ameen R; Sahu JK; Bansal D
    Seizure; 2022 Jul; 99():164-175. PubMed ID: 35487871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
    Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
    Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
    Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
    Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis.
    Zhang L; Wang J; Wang C
    Dev Med Child Neurol; 2022 Mar; 64(3):305-313. PubMed ID: 34590711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
    Samanta D
    Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
    Montouris GD; Wheless JW; Glauser TA
    Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
    Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
    Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
    Cramer JA; Sapin C; François C
    Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
    Sharawat IK; Panda PK; Panda P; Dawman L
    Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
    Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lennox-Gastaut syndrome: a comprehensive review.
    Asadi-Pooya AA
    Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials.
    Bialer M; Perucca E
    Epilepsia; 2020 Jun; 61(6):1082-1089. PubMed ID: 32452568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA).
    Hahn CD; Jiang Y; Villanueva V; Zolnowska M; Arkilo D; Hsiao S; Asgharnejad M; Dlugos D
    Epilepsia; 2022 Oct; 63(10):2671-2683. PubMed ID: 35841234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lennox-Gastaut syndrome: New treatments and treatments under investigation.
    Auvin S
    Rev Neurol (Paris); 2020 Jun; 176(6):444-447. PubMed ID: 32409177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.